Company · CIK 2044950

# Bambusa Therapeutics, Inc.

| CIK | [2044950](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002044950) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | none on EDGAR |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-299405 | First-time registration Filed | 2026-10-09 | 2026-10-09 | 1 |

## Filings

 2

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-10-09 | [S-1](https://www.sec.gov/Archives/edgar/data/2044950/000162828026065557/0001628280-26-065557-index.htm) Registration filed | 333-299405 | 0001628280-26-065557 |
| 2026-08-03 | [DRS](https://www.sec.gov/Archives/edgar/data/2044950/000162828026051869/0001628280-26-051869-index.htm) Draft made public | 377-09638 | 0001628280-26-051869 |

[All filings of this company](https://equitycapital.markets/filings?cik=2044950) · [CSV](https://equitycapital.markets/filings.csv?cik=2044950)

---
Source page: https://equitycapital.markets/company/2044950 · Data: U.S. SEC EDGAR · CC BY 4.0